TY - BOOK PY - 2020 DA - 2020// TI - Breast cancer facts & figures 2019–2020 PB - American Cancer Society Inc CY - Atlanta ID - ref1 ER - TY - JOUR AU - Evelhoch, J. L. PY - 1999 DA - 1999// TI - Key factors in the acquisition of contrast kinetic data for oncology JO - J Magn Reson Imaging VL - 10 UR - https://doi.org/3.0.CO;2-9 DO - 3.0.CO;2-9 ID - Evelhoch1999 ER - TY - JOUR AU - Schnall, M. D. AU - Blume, J. AU - Bluemke, D. A. PY - 2006 DA - 2006// TI - Diagnostic architectural and dynamic features at breast MR imaging: multicenter study JO - Radiology VL - 238 UR - https://doi.org/10.1148/radiol.2381042117 DO - 10.1148/radiol.2381042117 ID - Schnall2006 ER - TY - JOUR AU - Bluemke, D. A. AU - Gatsonis, C. A. AU - Chen, M. H. PY - 2004 DA - 2004// TI - Magnetic resonance imaging of the breast prior to biopsy JO - JAMA VL - 292 UR - https://doi.org/10.1001/jama.292.22.2735 DO - 10.1001/jama.292.22.2735 ID - Bluemke2004 ER - TY - JOUR AU - Saslow, D. AU - Boetes, C. AU - Burke, W. PY - 2007 DA - 2007// TI - American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography JO - CA Cancer J Clin VL - 57 UR - https://doi.org/10.3322/canjclin.57.2.75 DO - 10.3322/canjclin.57.2.75 ID - Saslow2007 ER - TY - JOUR AU - Chen, J. AU - Sun, Y. AU - Chen, Q. PY - 2016 DA - 2016// TI - Multifunctional gold nanocomposites designed for targeted CT/MR/optical trimodal imaging of human non-small cell lung cancer cells JO - Nanoscale VL - 8 UR - https://doi.org/10.1039/C6NR03143A DO - 10.1039/C6NR03143A ID - Chen2016 ER - TY - JOUR AU - Gweon, H. M. AU - Jeong, J. AU - Son, E. J. PY - 2017 DA - 2017// TI - The clinical significance of accompanying NME on preoperative MR imaging in breast cancer patients JO - PLoS ONE VL - 12 UR - https://doi.org/10.1371/journal.pone.0178445 DO - 10.1371/journal.pone.0178445 ID - Gweon2017 ER - TY - JOUR AU - Alili, C. AU - Pages, E. AU - Curros Doyon, F. PY - 2014 DA - 2014// TI - Correlation between MR imaging – prognosis factors and molecular classification of breast cancers JO - Diagn Interv Imaging VL - 95 UR - https://doi.org/10.1016/j.diii.2014.01.002 DO - 10.1016/j.diii.2014.01.002 ID - Alili2014 ER - TY - JOUR AU - Nwe, K. AU - Milenic, D. AU - Bryant, L. H. PY - 2011 DA - 2011// TI - Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI JO - J Inorg Biochem VL - 105 UR - https://doi.org/10.1016/j.jinorgbio.2011.01.017 DO - 10.1016/j.jinorgbio.2011.01.017 ID - Nwe2011 ER - TY - JOUR AU - Otis, J. B. AU - Zong, H. AU - Kotylar, A. PY - 2016 DA - 2016// TI - Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.9081 DO - 10.18632/oncotarget.9081 ID - Otis2016 ER - TY - JOUR AU - Peng, C. AU - Zheng, L. AU - Chen, Q. PY - 2012 DA - 2012// TI - PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography JO - Biomaterials VL - 33 UR - https://doi.org/10.1016/j.biomaterials.2011.10.052 DO - 10.1016/j.biomaterials.2011.10.052 ID - Peng2012 ER - TY - JOUR AU - Xiong, Z. AU - Wang, Y. AU - Zhu, J. PY - 2017 DA - 2017// TI - Dendrimers meet zwitterions: development of a unique antifouling nanoplatform for enhanced blood pool, lymph node and tumor CT imaging JO - Nanoscale VL - 9 UR - https://doi.org/10.1039/C7NR03940A DO - 10.1039/C7NR03940A ID - Xiong2017 ER - TY - JOUR AU - Kukowska-Latallo, J. F. AU - Candido, K. A. AU - Cao, Z. PY - 2005 DA - 2005// TI - Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3921 DO - 10.1158/0008-5472.CAN-04-3921 ID - Kukowska-Latallo2005 ER - TY - JOUR AU - Wong, P. T. AU - Choi, S. K. PY - 2015 DA - 2015// TI - Mechanisms of drug release in nanotherapeutic delivery systems JO - Chem Rev VL - 115 UR - https://doi.org/10.1021/cr5004634 DO - 10.1021/cr5004634 ID - Wong2015 ER - TY - JOUR AU - Engel, R. H. AU - Kaklamani, V. G. PY - 2007 DA - 2007// TI - HER2-positive breast cancer: current and future treatment strategies JO - Drugs VL - 67 UR - https://doi.org/10.2165/00003495-200767090-00006 DO - 10.2165/00003495-200767090-00006 ID - Engel2007 ER - TY - JOUR AU - Rexer, B. N. AU - Arteaga, C. L. PY - 2012 DA - 2012// TI - Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications JO - Crit Rev Oncog VL - 17 UR - https://doi.org/10.1615/CritRevOncog.v17.i1.20 DO - 10.1615/CritRevOncog.v17.i1.20 ID - Rexer2012 ER - TY - JOUR AU - Ross, J. S. AU - Slodkowska, E. A. AU - Symmans, W. F. PY - 2009 DA - 2009// TI - The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine JO - Oncologist VL - 14 UR - https://doi.org/10.1634/theoncologist.2008-0230 DO - 10.1634/theoncologist.2008-0230 ID - Ross2009 ER - TY - JOUR AU - Stern, H. M. PY - 2012 DA - 2012// TI - Improving treatment of HER2-positive cancers: opportunities and challenges JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3001539 DO - 10.1126/scitranslmed.3001539 ID - Stern2012 ER - TY - JOUR AU - Veeraraghavan, J. AU - Angelis, C. AU - Reis-Filho, J. S. PY - 2017 DA - 2017// TI - De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance JO - Breast VL - 34 UR - https://doi.org/10.1016/j.breast.2017.06.022 DO - 10.1016/j.breast.2017.06.022 ID - Veeraraghavan2017 ER - TY - JOUR AU - Wang, Y. C. AU - Morrison, G. AU - Gillihan, R. PY - 2011 DA - 2011// TI - Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers–role of estrogen receptor and HER2 reactivation JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr3067 DO - 10.1186/bcr3067 ID - Wang2011 ER - TY - JOUR AU - Spector, N. L. AU - Blackwell, K. L. PY - 2009 DA - 2009// TI - Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.22.1507 DO - 10.1200/JCO.2009.22.1507 ID - Spector2009 ER - TY - JOUR AU - Slamon, D. J. AU - Leyland-Jones, B. AU - Shak, S. PY - 2001 DA - 2001// TI - Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103153441101 DO - 10.1056/NEJM200103153441101 ID - Slamon2001 ER - TY - JOUR AU - Bosman, A. W. AU - Janssen, H. M. AU - Meijer, E. W. PY - 1999 DA - 1999// TI - About dendrimers: structure, physical properties, and applications JO - Chem Rev VL - 99 UR - https://doi.org/10.1021/cr970069y DO - 10.1021/cr970069y ID - Bosman1999 ER - TY - JOUR AU - Huang, X. B. AU - Zhou, D. Z. AU - Zeng, M. PY - 2017 DA - 2017// TI - Star poly(β-amino esters) obtained from the combination of linear Poly(β-amino esters) and polyethylenimine JO - ACS Macro Lett VL - 6 UR - https://doi.org/10.1021/acsmacrolett.7b00319 DO - 10.1021/acsmacrolett.7b00319 ID - Huang2017 ER - TY - JOUR AU - Luo, D. AU - Haverstick, K. AU - Belcheva, N. PY - 2002 DA - 2002// TI - Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible high-efficiency dna delivery JO - Macromolecules VL - 35 UR - https://doi.org/10.1021/ma0106346 DO - 10.1021/ma0106346 ID - Luo2002 ER - TY - JOUR AU - Xie, J. AU - Wang, J. AU - Chen, H. PY - 2015 DA - 2015// TI - Multivalent conjugation of antibody to dendrimers for the enhanced capture and regulation on colon cancer cells JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep09445 DO - 10.1038/srep09445 ID - Xie2015 ER - TY - JOUR AU - Kulhari, H. AU - Pooja, D. AU - Shrivastava, S. PY - 2016 DA - 2016// TI - Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep23179 DO - 10.1038/srep23179 ID - Kulhari2016 ER - TY - JOUR AU - Huang, Y. AU - Coman, D. AU - Hyder, F. PY - 2015 DA - 2015// TI - Dendrimer-based responsive MRI contrast agents (G1–G4) for biosensor imaging of redundant deviation in shifts (BIRDS) JO - Bioconjugate Chem VL - 26 UR - https://doi.org/10.1021/acs.bioconjchem.5b00568 DO - 10.1021/acs.bioconjchem.5b00568 ID - Huang2015 ER - TY - JOUR AU - Li, K. AU - Wen, S. AU - Larson, A. C. PY - 2013 DA - 2013// TI - Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer JO - Int J Nanomed VL - 8 UR - https://doi.org/10.2147/IJN.S46177 DO - 10.2147/IJN.S46177 ID - Li2013 ER - TY - JOUR AU - Shukla, R. AU - Thomas, T. P. AU - Desai, A. M. PY - 2008 DA - 2008// TI - HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb JO - Nanotechnology. VL - 19 UR - https://doi.org/10.1088/0957-4484/19/29/295102 DO - 10.1088/0957-4484/19/29/295102 ID - Shukla2008 ER - TY - JOUR AU - Wang, L. PY - 2017 DA - 2017// TI - Early diagnosis of breast cancer JO - Sensors (Basel) VL - 17 UR - https://doi.org/10.3390/s17071572 DO - 10.3390/s17071572 ID - Wang2017 ER - TY - JOUR AU - Grueneisen, J. AU - Nagarajah, J. AU - Buchbender, C. PY - 2015 DA - 2015// TI - Positron emission tomography/magnetic resonance imaging for local tumor staging in patients with primary breast cancer: a comparison with positron emission tomography/computed tomography and magnetic resonance imaging JO - Invest Radiol VL - 50 UR - https://doi.org/10.1097/RLI.0000000000000197 DO - 10.1097/RLI.0000000000000197 ID - Grueneisen2015 ER - TY - JOUR AU - Lenchik, L. AU - Heacock, L. AU - Weaver, A. A. PY - 2019 DA - 2019// TI - Automated segmentation of tissues using CT and MRI: a systematic review JO - Acad Radiol VL - 26 UR - https://doi.org/10.1016/j.acra.2019.07.006 DO - 10.1016/j.acra.2019.07.006 ID - Lenchik2019 ER - TY - JOUR AU - Liu, J. AU - Xiong, Z. AU - Zhang, J. PY - 2019 DA - 2019// TI - Zwitterionic gadolinium(III)-complexed dendrimer-entrapped gold nanoparticles for enhanced computed tomography/magnetic resonance imaging of lung cancer metastasis JO - ACS Appl Mater Interfaces VL - 11 UR - https://doi.org/10.1021/acsami.8b21679 DO - 10.1021/acsami.8b21679 ID - Liu2019 ER - TY - JOUR AU - Li, X. AU - Xia, S. AU - Zhou, W. PY - 2019 DA - 2019// TI - Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer JO - Int J Nanomedicine VL - 14 UR - https://doi.org/10.2147/IJN.S189252 DO - 10.2147/IJN.S189252 ID - Li2019 ER - TY - JOUR AU - Dong, Q. AU - Yang, H. AU - Wan, C. PY - 2019 DA - 2019// TI - Her2-functionalized gold-nanoshelled magnetic hybrid nanoparticles: a theranostic agent for dual-modal imaging and photothermal therapy of breast cancer JO - Nanoscale Res Lett VL - 14 UR - https://doi.org/10.1186/s11671-019-3053-4 DO - 10.1186/s11671-019-3053-4 ID - Dong2019 ER - TY - JOUR AU - Fares, J. AU - Kanojia, D. AU - Rashidi, A. PY - 2019 DA - 2019// TI - Diagnostic clinical trials in breast cancer brain metastases: barriers and innovations JO - Clin Breast Cancer VL - 19 UR - https://doi.org/10.1016/j.clbc.2019.05.018 DO - 10.1016/j.clbc.2019.05.018 ID - Fares2019 ER - TY - JOUR AU - Han, C. AU - Zhang, A. AU - Kong, Y. PY - 2019 DA - 2019// TI - Multifunctional iron oxide-carbon hybrid nanoparticles for targeted fluorescent/MR dual-modal imaging and detection of breast cancer cells JO - Anal Chim Acta VL - 1067 UR - https://doi.org/10.1016/j.aca.2019.03.054 DO - 10.1016/j.aca.2019.03.054 ID - Han2019 ER - TY - JOUR AU - Chu, C. H. AU - Cheng, S. H. AU - Chen, N. T. PY - 2019 DA - 2019// TI - Microwave-synthesized platinum-embedded mesoporous silica nanoparticles as dual-modality contrast agents: computed tomography and optical imaging JO - Int J Mol Sci. VL - 20 UR - https://doi.org/10.3390/ijms20071560 DO - 10.3390/ijms20071560 ID - Chu2019 ER - TY - JOUR AU - Marinovich, M. L. AU - Sardanelli, F. AU - Ciatto, S. PY - 2012 DA - 2012// TI - Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI JO - Breast VL - 21 UR - https://doi.org/10.1016/j.breast.2012.07.006 DO - 10.1016/j.breast.2012.07.006 ID - Marinovich2012 ER - TY - JOUR AU - Bouzon, A. AU - Acea, B. AU - Soler, R. PY - 2016 DA - 2016// TI - Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients JO - Radiol Oncol VL - 50 UR - https://doi.org/10.1515/raon-2016-0007 DO - 10.1515/raon-2016-0007 ID - Bouzon2016 ER - TY - JOUR AU - Fiordelisi, M. F. AU - Auletta, L. AU - Meomartino, L. PY - 2019 DA - 2019// TI - Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models JO - Contrast Media Mol Imaging VL - 2019 UR - https://doi.org/10.1155/2019/8946729 DO - 10.1155/2019/8946729 ID - Fiordelisi2019 ER - TY - JOUR AU - Wang, S. H. AU - Lu, L. AU - Fan, Y. PY - 2013 DA - 2013// TI - Characterization of a novel transgenic mouse tumor model for targeting HER2+ cancer stem cells JO - Int J Biol Sci VL - 10 UR - https://doi.org/10.7150/ijbs.6309 DO - 10.7150/ijbs.6309 ID - Wang2013 ER -